Mostrando 10 resultados de: 16
Filtros aplicados
Publisher
Medicina (Argentina)(3)
Acta Tropica(2)
Clinical and Vaccine Immunology(1)
International Journal of Dermatology(1)
Investigacion Clinica(1)
Área temáticas
Medicina forense; incidencia de enfermedades(6)
Farmacología y terapéutica(5)
Microorganismos, hongos y algas(5)
Ginecología, obstetricia, pediatría, geriatría(3)
Medicina y salud(2)
Origen
scopus(16)
Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases
ArticleAbstract: Leishmaniasis is a parasitic disease caused by hemoflagellates of the genus Leishmania and is transmPalabras claves:Cutaneous leishmaniasis, Leishmania (L.) amazonensis, Leishmania (L.) infantum, Leishmania (V.) braziliensis, Mucocutaneous leishmaniasis, Visceral leishmaniasisAutores:Alejandra Beatriz Barrio, Basombŕo M.A., Beckar J., Fabricio Miguel Locatelli, González-Prieto G., Hashiguchi Y., Jaime D., Jorge Diego Marco, María Celia Mora, María Fernanda García Bustos, Monroig S., Moreno S., Parodi C.M., Ramos F., Sajama J., Yeo M.Fuentes:scopusB-cell profile, B-cell activating factor concentration and IgG levels in human cutaneous and mucosal leishmaniasis
ArticleAbstract: Aims: The aim of this study was to evaluate characteristics of B cells in human tegumentary leismaniPalabras claves:B lymphocytes, B-cell activating factor, Cutaneous leishmaniasis, hypergammaglobulinemia, interferon-gamma, Interleukin-6, Mucocutaneous leishmaniasisAutores:Albareda M.C., Alejandra Beatriz Barrio, Badano N., Castro Eiro M.E., de Elizalde de Bracco M.M., González Prieto A.G., Laucella S.A., María Fernanda García Bustos, Parodi C.M., Pimentel J.Fuentes:scopusAn appraisal of the scientific current situation and new perspectives in the treatment of cutaneous leishmaniasis
ArticleAbstract: Leishmaniasis is a Neglected Tropical Diseases caused by protozoan parasites of the genus LeishmaniaPalabras claves:Current therapy, Cutaneous leishmaniasis, Improved treatment, In vivo assayAutores:Bermúdez J.M., Briones Nieva C.A., Cid A.G., María Fernanda García Bustos, Romero A.I., Villegas M.Fuentes:scopusAlterations of immunological parameters in an autochthonous case of visceral leishmaniasis from the northwest of Argentina
ArticleAbstract: We report the alterations of immunological parameters of a patient with visceral leishmaniasis causePalabras claves:B-lymphocyte differentiation, cytokines, T-lymphocyte differentiation, Visceral leishmaniasisAutores:Alejandra Beatriz Barrio, Basombŕo M.A., de Bracco M.M.d.E., María Celia Mora, María Fernanda García Bustos, Parodi C.M., Ramos F.Fuentes:scopusAmerican cutaneous leishmaniasis in infancy and childhood
ReviewAbstract: Infant and young child skin diseases are among the most common features of morbidity throughout thePalabras claves:Autores:María Fernanda García Bustos, Marquez M., Pániz-Mondolfi A.E., Pérez Alvarez A.M., Rodriguez-Morales A.J., Rosales T., Tálamo Sánchez A.I., Talhari C., Villamil-Gomez W.E.Fuentes:scopusAmerican tegumentary leishmaniasis: T-cell differentiation profile of cutaneous and mucosal forms—co-infection with Trypanosoma cruzi
ArticleAbstract: American tegumentary leishmaniasis displays two main clinical forms: cutaneous (CL) and mucosal (ML)Palabras claves:Cutaneous leishmaniasis, Differentiation and memory phenotype, Leishmania–T. cruzi co-infection, Mucosal leishmaniasis, Peripheral T lymphocytesAutores:Alejandra Beatriz Barrio, Baré P., Basombŕo M.A., de Elizalde de Bracco M.M., González Prieto A.G., María Celia Mora, María Fernanda García Bustos, Parodi C.M., Ramos F.Fuentes:scopusEvaluation of different total leishmania amazonensis antigens for the development of a first-generation vaccine formulated with a toll-like receptor-3 agonist to prevent cutaneous leishmaniasis
ArticleAbstract: BACKGROUND Unfortunately, no any vaccine against leishmaniasis has been developed for human use. ThePalabras claves:L.Amazonensis, leishmaniasis, Poly (I:C), Whole-cell vaccineAutores:Bruna F.A., Cargnelutti D.E., Fernandes A.P., Germanó M.J., Lochedino A.L.S., Lozano E.S., Mackern-Oberti J.P., María Fernanda García Bustos, Salomón M.C., Sanchez M.V.Fuentes:scopusMore about miltefosine in the treatment of mucosal leishmaniasis
OtherAbstract:Palabras claves:Autores:Alejandra Beatriz Barrio, Basombŕo M.A., María Fernanda García BustosFuentes:scopusIn vivo antileishmanial efficacy of miltefosine against Leishmania (Leishmania) amazonensis
ArticleAbstract: Leishmaniasis, a disease caused by parasites of the Leishmania genus, constitutes a significant healPalabras claves:Autores:Alejandra Beatriz Barrio, Basombŕo M.A., Cimino R.O., De Raspi E.M., María Fernanda García Bustos, Parada L.A., Parodi C.M., Prieto G.G., Rubén Marino Cardozo, Soto J., Uncos D.A., Yeo M.Fuentes:scopusImmunological correlates of cure in the first American Cutaneous Leishmaniasis patient treated by immunotherapy in Argentina. A case report
ArticleAbstract: A patient with localized cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis infectioPalabras claves:Immunology, leishmaniasis, TreatmentAutores:Alejandra Beatriz Barrio, Basombŕo M.A., Convit J., María Celia Mora, María Fernanda García Bustos, Ramoneda C.M.P., Ramos F.Fuentes:scopus